Compounds for inflammation and immune-related uses

Details for Australian Patent Application No. 2006208045 (hide)

Owner Synta Pharmaceuticals Corp.

Inventors Chen, Shoujun; Yu, Chih-yi; Xie, Yu; Jiang, Jun; Sun, Lijun

Agent Shelston IP

Pub. Number AU-B-2006208045

PCT Pub. Number WO2006/081391

Priority 60/646,683 25.01.05 US

Filing date 25 January 2006

Wipo publication date 3 August 2006

Acceptance publication date 30 August 2012

International Classifications

C07D 239/02 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/4965 - Non-condensed pyrazines

A61K 31/50 - Pyridazines

A61K 31/505 - Pyrimidines

C07D 401/00 Heterocyclic compounds containing two or more hetero rings

C07D 403/00 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/00 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/00 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 411/00 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms

C07D 413/00 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/00 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 419/00 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/081391 Priority application(s): WO2006/081391

4 October 2007 Change of Name(s) of Applicant(s), Section 104

  Yu, Xie; Synta Pharmaceuticals Corp. The name of the applicant has been changed to Synta Pharmaceuticals Corp.

30 August 2012 Application Accepted

  Published as AU-B-2006208045

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006208046-N-halogenated amino acids and N, Ndihalogenated amino acids in combination with hypohalous acids

2006208043-Thiophene compounds for inflammation and immune-related uses